Robinhood Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.1M Sell
69,349
-3,057
-4% -$784K 0.86% 19
2026
Q2
$18.2M Sell
72,406
-16,716
-19% -$3.6M 0.97% 19
2026
Q1
$19.4M Buy
89,122
+20,057
+29% +$4.45M 1.41% 16
2025
Q4
$15.8M Buy
+69,065
New +$15.7M 1.26% 18

Other funds holding ABBV

Robinhood Asset Management's ABBV Position: Q3 2026 in Review

Robinhood Asset Management reduced its AbbVie (ABBV) stake by 4.2% in Q3 2026, selling an estimated $784K and leaving 69,349 shares worth $18.1M. The position accounts for 0.86% of the portfolio, ranked #19.

Robinhood Asset Management first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. The position peaked at $19.4M in Q1 2026. 4,283 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Robinhood Asset Management held 69,349 shares of AbbVie worth $18.1M as of Q3 2026.
  • Robinhood Asset Management sold 3,057 AbbVie shares in Q3 2026, an estimated $784K.
  • AbbVie made up 0.86% of Robinhood Asset Management's portfolio in Q3 2026, its #19 holding.
  • Robinhood Asset Management first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • Robinhood Asset Management's AbbVie position peaked at $19.4M in Q1 2026.
  • 4,283 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Robinhood Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.